** H-shares of WuXi AppTec rise 6.4% to HK$56.10, the highest since Oct. 10
** Stock third-biggest pct gainer on Hang Seng Index and fourth-biggest on Hang Seng Commerce & Industry Index
, which are up 0.6% and 0.9%, respectively
** Chinese new drug research and development group posts 17% fall in Q3 net profit, 1.96% decline in revenue
** Jefferies maintains "buy", saying Q3 results in-line with expectations and market consensus
** Sees accelerating growth for total backlog, indicating stronger revenue momentum ahead
** Co's Shanghai-listed stock up 5.1% to 56.15 yuan
** Hong Kong stock down 31.2% YTD
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。